iPS-derived cells become part of rat's heart tissue, doctor says

iPS-derived cells become part of rat's heart tissue, doctor says

Osaka University professor Yoshiki Sawa, a cardiovascular surgeon, reports at a press conference in Osaka, western Japan, on Jan. 25, 2015, that a cardiac muscle sheet of induced pluripotent stem (iPS) cells has assimilated with the heart tissue of a rat. (Kyodo) ==Kyodo

  • Product Code
  • ILEA000062990
  • Registered date
  • 2015/1/26 11:24:22
  • Credit
  • Kyodo / Kyodo News Images
  • Media source
  • Media size
  • 2633 × 3968 pixel
  • Resolution
  • 240 dpi
  • Deployment size
  • 1.02(MB)*
  • Special instruction

*File size when opened in Photoshop, etc.

Similar Images & Videos
    Japan gov't panel approves 2 iPS-derived drugs

    Japan gov't panel approves 2 iPS-derived drugs

    University of Osaka professor Yoshiki Sawa holds a press conference in Osaka on Feb. 19, 2026, after Japan's health ministry panel approved the commercialization of two regenerative medicine products prepared from iPS cells, the first of their kind in the world. One of the two drugs, ReHeart, heart muscle sheets derived from human iPS cells, was developed by a startup originating from Sawa's team at the university.
      Japan gov't panel approves 2 iPS-derived drugs

      Japan gov't panel approves 2 iPS-derived drugs

      University of Osaka professor Yoshiki Sawa holds a press conference in Osaka on Feb. 19, 2026, after Japan's health ministry panel approved the commercialization of two regenerative medicine products prepared from iPS cells, the first of their kind in the world. One of the two drugs, ReHeart, heart muscle sheets derived from human iPS cells, was developed by a startup originating from Sawa's team at the university.
        Japan gov't panel approves 2 iPS-derived drugs

        Japan gov't panel approves 2 iPS-derived drugs

        University of Osaka professor Yoshiki Sawa holds a press conference in Osaka on Feb. 19, 2026, after Japan's health ministry panel approved the commercialization of two regenerative medicine products prepared from iPS cells, the first of their kind in the world. One of the two drugs, ReHeart, heart muscle sheets derived from human iPS cells, was developed by a startup originating from Sawa's team at the university.
          Japan gov't panel approves 2 iPS-derived drugs

          Japan gov't panel approves 2 iPS-derived drugs

          File photo taken on Jan. 23, 2024, at the University of Osaka in Suita, Osaka Prefecture, shows iPS cell-derived cardiomyocyte sheet to treat severe heart failure.
            Japan gov't panel approves 2 iPS-derived drugs

            Japan gov't panel approves 2 iPS-derived drugs

            File photo taken on Jan. 23, 2024, at the University of Osaka in Suita, Osaka Prefecture, shows iPS cell-derived cardiomyocyte sheet to treat severe heart failure.

              Nobel Prize in chemistry winner Kitagawa

              KYOTO, Japan, Oct. 9 Kyodo - Kyoto University distinguished professor Susumu Kitagawa attends a press conference in the western Japan city on Oct. 8, 2025, after being named one of the three winners of the Nobel Prize in Chemistry earlier in the day for developing porous materials that can store and release gases such as natural gas. (Kyodo)
                Nobel Prize in medicine winner Sakaguchi

                Nobel Prize in medicine winner Sakaguchi

                Shimon Sakaguchi, a distinguished professor at Osaka University, alongside his wife, Noriko, attends a press conference in Suita, Osaka Prefecture, western Japan, on Oct. 7, 2025, a day after being named the winner of the Nobel Prize in Physiology or Medicine, along with two American scientists, for "groundbreaking" discoveries on how the immune system is kept in check.
                  Nobel Prize in medicine winner Sakaguchi

                  Nobel Prize in medicine winner Sakaguchi

                  Shimon Sakaguchi, a distinguished professor at Osaka University, alongside his wife, Noriko, attends a press conference in Suita, Osaka Prefecture, western Japan, on Oct. 7, 2025, a day after being named the winner of the Nobel Prize in Physiology or Medicine, along with two American scientists, for "groundbreaking" discoveries on how the immune system is kept in check.
                    Nobel Prize in medicine winner Sakaguchi

                    Nobel Prize in medicine winner Sakaguchi

                    Shimon Sakaguchi, a distinguished professor at Osaka University, alongside his wife, Noriko, attends a press conference in Suita, Osaka Prefecture, western Japan, on Oct. 7, 2025, a day after being named the winner of the Nobel Prize in Physiology or Medicine, along with two American scientists, for "groundbreaking" discoveries on how the immune system is kept in check.
                      Nobel Prize in medicine winner Sakaguchi

                      Nobel Prize in medicine winner Sakaguchi

                      Shimon Sakaguchi, a distinguished professor at Osaka University, attends a press conference in Suita, Osaka Prefecture, western Japan, on Oct. 7, 2025, a day after being named the winner of the Nobel Prize in Physiology or Medicine with two American scientists for their "groundbreaking" discoveries on how the immune system is kept in check.